S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

GeneNews (GEN) News Today

SourceHeadline
msn.com logoVertex, Crispr Get Second FDA Approval for Gene Therapy
msn.com - January 18 at 4:04 PM
msn.com logoGene-editing treatment from Vertex and CRISPR cleared for second rare blood disorder
msn.com - January 17 at 5:58 PM
msn.com logoFDA expands use of newly approved CRISPR therapy
msn.com - January 17 at 5:58 PM
washingtonpost.com logoOhio St hires Texas A&M athletic director Ross Bjork to replace the retiring Gene Smith
washingtonpost.com - January 16 at 8:53 PM
msn.com logoMutated gene thought to exist in just 4% of people could ‘help tackle obesity’
msn.com - November 27 at 4:35 PM
nytimes.com logoSickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
nytimes.com - November 18 at 7:54 AM
msn.com logoUK authorizes gene therapy for blood disorders in world first
msn.com - November 17 at 3:18 PM
msn.com logoMac Jones Losing Support of Patriots Teammates After Being Benched for Third Time, Report
msn.com - November 16 at 8:25 AM
usatoday.com logoGene Frenette: Mac Jones' decline with Patriots also a product of Bill Belichick negligence
usatoday.com - November 16 at 8:25 AM
msn.com logoSarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
msn.com - October 31 at 10:37 PM
wsj.com logoSarepta Therapeutics Stock Dives After New Gene Therapy Data
wsj.com - October 31 at 10:37 PM
msn.com logoFDA panel considers gene therapy as a potential cure for the sickest sickle cell patients
msn.com - October 31 at 5:37 PM
marketwatch.com logoOncology Molecular Diagnostics Market by 2031
marketwatch.com - March 27 at 8:00 AM
marketwatch.com logoGlobal Colorectal Cancer Diagnostic Market Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2030 By VMReports
marketwatch.com - March 19 at 1:04 PM
thestreet.com logoBiotech Stock Mailbag: GenVec
thestreet.com - January 5 at 12:09 PM
investing.com logoStageZero Life Sciences Ltd (SZLS)
investing.com - February 23 at 4:51 PM
Get GeneNews News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (Ad)

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

[Get Your Insights Now]

GEN Media Mentions By Week

GEN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GEN
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

GEN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GEN Articles
This Week

0

1

GEN Articles
Average Week

Get GeneNews News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (TSE:GEN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners